Zeitschriftenartikel zum Thema „Accomodation support“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Accomodation support" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Russo, Alexandra, Francesca Alt, Marie Astrid Neu, Stefan Eder, Arthur Wingerter, Khalifa El Malki, Bernhard Lammle und Joerg Faber. „Hemophagocytic Lymphohistiocytosis in Early Infancy- Pitfall of Differentiation between Hereditary and Infectious Reasons“. Blood 132, Supplement 1 (29.11.2018): 4961. http://dx.doi.org/10.1182/blood-2018-99-117519.
Der volle Inhalt der QuelleBarco, Stefano, Stefanie Sollfrank, Alice Trinchero, Luigi Tomao, Barbara Zieger, Johanna A. Kremer Hovinga, Laura Conti et al. „Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature“. Blood 132, Supplement 1 (29.11.2018): 2496. http://dx.doi.org/10.1182/blood-2018-99-116030.
Der volle Inhalt der QuelleGorodianska, L., und L. Tsiukalo. „THE SOURCES FOR FINANCING THE ACCOMODATION SUPPORT IN THE ARMED FORCES OF UKRAINE“. Visnyk Taras Shevchenko National University of Kyiv. Military-Special Sciences, Nr. 3 (47) (2021): 31–37. http://dx.doi.org/10.17721/1728-2217.2021.47.31-37.
Der volle Inhalt der QuelleKomorowska, Olga. „Funkcjonowanie dorosłych osób z niepełnosprawnością w Niemczech“. Ekonomia 23, Nr. 1 (15.03.2017): 11–21. http://dx.doi.org/10.19195/2084-4093.23.1.2.
Der volle Inhalt der QuelleRiyanto, Sugeng. „KERANGKA PENGEMBANGAN SITUS CANDI LOSARI: Kajian Awal untuk Pengembangan Penelitian, Pendidikan, dan Kepariwisataan“. Berkala Arkeologi 28, Nr. 1 (28.05.2008): 46–56. http://dx.doi.org/10.30883/jba.v28i1.354.
Der volle Inhalt der QuelleSzenes, Eva, Andrea Härzschel, Erika Tissino, Pischeli Justine, Julia Gutjahr, Sandra Pennisi, Jan Höpner et al. „BCR-Induced VLA-4 Activation in the TCL1 Transgenic Mouse Model for Chronic Lymphocytic Leukemia“. Blood 134, Supplement_1 (13.11.2019): 1730. http://dx.doi.org/10.1182/blood-2019-125634.
Der volle Inhalt der QuellePleyer, Lisa, Michael Pfeilstocker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger et al. „Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group“. Blood 134, Supplement_1 (13.11.2019): 3821. http://dx.doi.org/10.1182/blood-2019-128153.
Der volle Inhalt der QuelleSimon, Florian, Adam Giza, Sandra Robrecht, Anna-Maria Fink, Paula Cramer, Julia Von Tresckow, Moritz Fürstenau et al. „Pooled Analysis of First-Line Treatment with Targeted Agents in Patients with Chronic Lymphocytic Leukemia (CLL) Aged 80 Years and Older“. Blood 138, Supplement 1 (05.11.2021): 1552. http://dx.doi.org/10.1182/blood-2021-150698.
Der volle Inhalt der QuelleBröckelmann, Paul J., Annette Plütschow, Richard Greil, Josée M. Zijlstra, Timothy Illidge, Alexander Fosså, Julia Meissner et al. „Abscopal Effect of Radiotherapy and Nivolumab in Relapsed or Refractory Hodgkin Lymphoma (AERN): An International Multicenter Single-Arm Two-Stage Phase II GHSG Trial“. Blood 134, Supplement_1 (13.11.2019): 1547. http://dx.doi.org/10.1182/blood-2019-124351.
Der volle Inhalt der QuelleRiyanti, Anti, und Andhika Chandra Lesmana. „Pengembangan Daya Tarik Wisata di Kaliurang, Yogyakarta“. Journal of Indonesian Tourism, Hospitality and Recreation 5, Nr. 1 (01.04.2022): 115–26. http://dx.doi.org/10.17509/jithor.v5i1.45008.
Der volle Inhalt der QuelleFürstenau, Moritz, Anke Schilhabel, Sandra Robrecht, Can Zhang, Julia Von Tresckow, Carsten Utoft Niemann, Arnon P. Kater et al. „High Resolution Assessment of Minimal Residual Disease (MRD) By Next-Generation Sequencing (NGS) and High-Sensitivity Flow Cytometry (hsFCM) in the Phase 3 GAIA (CLL13) Trial“. Blood 138, Supplement 1 (05.11.2021): 72. http://dx.doi.org/10.1182/blood-2021-147729.
Der volle Inhalt der QuelleAbdullah, Taufik, und Kiki Pebriyanti. „PENGARUH PROGRAM GREEN HOTEL TERHADAP KEPUTUSAN MENGINAP TAMU DI THE ROYALE KRAKATAU HOTEL CILEGON BANTEN“. Journal : Tourism and Hospitality Essentials Journal 6, Nr. 1 (07.04.2016): 1023. http://dx.doi.org/10.17509/thej.v6i1.2013.
Der volle Inhalt der QuelleFürstenau, Moritz, Sandra Robrecht, Can Zhang, Julia Von Tresckow, Carsten Utoft Niemann, Arnon P. Kater, Michael Gregor et al. „Comparison of Tumor Lysis Syndrome (TLS) Risk Reduction and Incidence in Different Venetoclax-Based Combinations within the Randomized Phase 3 GAIA (CLL13) Trial“. Blood 138, Supplement 1 (05.11.2021): 2639. http://dx.doi.org/10.1182/blood-2021-147790.
Der volle Inhalt der QuelleRummel, Mathias J., Christian Lerchenmüller, Manfred Hensel, Martin Goerner, Christian Buske, Holger Schulz, Burkhard Schmidt et al. „Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Waldenström's Macroglobulinemia (MW): Results of a Prospective, Randomized, Multicenter Phase 3 Study (the StiL NHL7-2008 MAINTAIN trial)“. Blood 134, Supplement_1 (13.11.2019): 343. http://dx.doi.org/10.1182/blood-2019-121909.
Der volle Inhalt der QuelleLudwig, Heinz, Siegfried Sormann, Niklas Zojer, Johannes Andel, Bernd L. Hartmann, Christoph Tinchon, Eberhard Gunsilius et al. „Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Efficacy Analysis of Combined Data (AGMT MM-02)“. Blood 134, Supplement_1 (13.11.2019): 696. http://dx.doi.org/10.1182/blood-2019-127954.
Der volle Inhalt der QuelleEichhorst, Barbara, Carsten Niemann, Arnon P. Kater, Moritz Fürstenau, Julia Von Tresckow, Can Zhang, Sandra Robrecht et al. „A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial“. Blood 138, Supplement 1 (05.11.2021): 71. http://dx.doi.org/10.1182/blood-2021-146161.
Der volle Inhalt der QuelleWidiantara, Ida Bagus Gde, und I. Wayan Suastawa. „Warm Water Pool System Simulation: Design and Manufacture“. Logic : Jurnal Rancang Bangun dan Teknologi 20, Nr. 3 (30.11.2020): 205–9. http://dx.doi.org/10.31940/logic.v20i3.2136.
Der volle Inhalt der QuelleBartle, John, Agustí Bosch und Lluís Orriols. „The policy mood in Spain: the thermostat in a warm climate, 1978–2017“. European Political Science Review 12, Nr. 2 (14.02.2020): 133–53. http://dx.doi.org/10.1017/s175577392000003x.
Der volle Inhalt der QuelleEl Hafizah, Nafilah, Ervina Ahyudanari und Valeriana Lukitosari. „Tourist Response as Water-based Seaplane Purposes for Island Tourism: A Literature Review“. E3S Web of Conferences 434 (2023): 02021. http://dx.doi.org/10.1051/e3sconf/202343402021.
Der volle Inhalt der QuelleBernard, Sophie, Hervé Ghesquieres, Rene-Olivier Casasnovas, Maria Gomes Da Silva, Pierre Feugier, Franck Morschhauser, Judith Trotman et al. „Lenalidomide As Maintenance Therapy after R-CHOP Has No Protecting Effect for Central Nervous System Relapse in Frontline Treatment of Diffuse Large B-Cells Lymphoma. an Ancillary Studies of the Remarc Study“. Blood 136, Supplement 1 (05.11.2020): 22–23. http://dx.doi.org/10.1182/blood-2020-136912.
Der volle Inhalt der QuelleAnggoro, Rena Ratri, und Mochammad Bagus Qomaruddin. „ASSOCIATIVE SOCIAL INTERACTIONS OF EX-LEPROSY PATIENTS IN SUMBERGLAGAH VILLAGE OF MOJOKERTO REGENCY“. Indonesian Journal of Public Health 14, Nr. 1 (05.07.2019): 127. http://dx.doi.org/10.20473/ijph.v14i1.2019.130-140.
Der volle Inhalt der QuelleAnggoro, Rena Ratri, und Mochammad Bagus Qomaruddin. „INTERAKSI SOSIAL ASOSIATIF EKS PENDERITA KUSTA DI DUSUN SUMBERGLAGAH, KABUPATEN MOJOKERTO“. Indonesian Journal of Public Health 14, Nr. 1 (05.07.2019): 127. http://dx.doi.org/10.20473/ijph.v14i1.2019.127-137.
Der volle Inhalt der QuelleDharawanij, Noppadol. „The Ways to Promote Wellness Tourism in Muang District, Chachoengsao Province“. International Journal of Professional Business Review 8, Nr. 12 (18.12.2023): e04009. http://dx.doi.org/10.26668/businessreview/2023.v8i12.4009.
Der volle Inhalt der QuelleBrauneck, Franziska, Brit Fischer, Jasmin Wellbrock, Carsten Bokemeyer, Julian Schulze zur Wiesch, Friedrich Haag, Christin Ackermann und Walter Fiedler. „Blockade of Tigit on AML-Derived M2 Macrophages Results in Reprograming into the M1 Phenotype and Enhances CD47-Mediated Phagocytosis“. Blood 138, Supplement 1 (05.11.2021): 3351. http://dx.doi.org/10.1182/blood-2021-148075.
Der volle Inhalt der QuelleSeymour, John F., Jenny Qun Wu, Relja Popovic, Barbara Eichhorst, Peter Hillmen, Thomas J. Kipps, Anton W. Langerak et al. „Assessment of the Clonal Dynamics of Acquired Mutations in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Treated in the Randomized Phase 3 Murano Trial Supports Venetoclax-Rituximab (VenR) Fixed-Duration Combination Treatment (Tx)“. Blood 138, Supplement 1 (05.11.2021): 1548. http://dx.doi.org/10.1182/blood-2021-147731.
Der volle Inhalt der QuelleBottoni, Stefano. „Talking to the System: Imre Mikó, 1911–1977“. East Central Europe 44, Nr. 1 (23.06.2017): 47–75. http://dx.doi.org/10.1163/18763308-04401002.
Der volle Inhalt der QuelleClement-Filliatre, Lauriane, Lotfi Benboubker, Anne-Marie Stoppa, Philippe Rodon, Kamel Laribi, Laure Vincent, Philippe Collet et al. „Real-Life-Setting Effectiveness of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma: The Remix Study“. Blood 136, Supplement 1 (05.11.2020): 25–26. http://dx.doi.org/10.1182/blood-2020-133807.
Der volle Inhalt der QuelleKillaspy, Helen, Stefan Priebe, Michael King, Sandra Eldridge, Paul McCrone, Geoff Shepherd, Maurice Arbuthnott et al. „Supported accommodation for people with mental health problems: the QuEST research programme with feasibility RCT“. Programme Grants for Applied Research 7, Nr. 7 (September 2019): 1–82. http://dx.doi.org/10.3310/pgfar07070.
Der volle Inhalt der QuelleMina, Roberto, Alessandra Larocca, Maria Teresa Petrucci, Gianluca Gaidano, Stelvio Ballanti, Pellegrino Musto, Massimo Offidani et al. „Long-Term Carfilzomib for High-Risk Patients with Newly Diagnosed Multiple Myeloma: A Pooled Analysis of Two Phase 1/2 Studies“. Blood 132, Supplement 1 (29.11.2018): 3240. http://dx.doi.org/10.1182/blood-2018-99-112075.
Der volle Inhalt der QuelleBlum, Sabine, Norbert Gattermann, Filipe Martins, Kathrin Nachtkamp, Andrea Kuendgen, Guido Kobbe und Ulrich Germing. „Is the IPSS-R Useful for Patients with MDS Receiving Disease-Modifying Treatment?“ Blood 128, Nr. 22 (02.12.2016): 5526. http://dx.doi.org/10.1182/blood.v128.22.5526.5526.
Der volle Inhalt der QuelleBelada, David, Katerina Kopeckova, Juan Miguel Bergua Burgues, Don Stevens, Marc André, Ernesto Pérez Persona, Petra Pichler et al. „First-Mind: Primary Analysis from a Phase Ib, Open-Label, Randomized Study to Assess Safety of Tafasitamab or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma“. Blood 138, Supplement 1 (05.11.2021): 3556. http://dx.doi.org/10.1182/blood-2021-148354.
Der volle Inhalt der QuelleMacro, Magaret, Cyrille Touzeau, Clara Mariette, Salomon Manier, Sabine Brechignac, Laure Vincent, Benjamin Hebraud et al. „Ixazomib and Daratumumab without Dexamethasone (I-Dara) in Elderly Frail RRMM Patients. a Multicenter Phase 2 Study (IFM 2018-02) of the Intergroupe Francophone Du Myélome (IFM)“. Blood 138, Supplement 1 (05.11.2021): 83. http://dx.doi.org/10.1182/blood-2021-148152.
Der volle Inhalt der QuelleBringhen, Sara, Roberto Mina, Maria Teresa Petrucci, Lorenzo De Paoli, Stelvio Ballanti, Pellegrino Musto, Massimo Offidani et al. „Once Weekly Versus Twice Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Pooled Analysis of Two Phase 1/2 Studies“. Blood 132, Supplement 1 (29.11.2018): 1990. http://dx.doi.org/10.1182/blood-2018-99-111252.
Der volle Inhalt der QuellePleyer, Lisa, Michael Leisch, Alexandra Kourakli, Eric Padron, Jaroslaw P. Maciejewski, Blanca Xicoy, Jennifer Kaivers et al. „Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study Group“. Blood 134, Supplement_1 (13.11.2019): 844. http://dx.doi.org/10.1182/blood-2019-123941.
Der volle Inhalt der QuelleZaccaria, Gian Maria, Andrea Capra, Maria Teresa Petrucci, Massimo Offidani, Vittorio Montefusco, Francesco Di Raimondo, Annalisa Bernardini et al. „Predictive Model of Early Relapse in Newly Diagnosed Multiple Myeloma: Analysis from a Pooled Dataset“. Blood 134, Supplement_1 (13.11.2019): 2130. http://dx.doi.org/10.1182/blood-2019-125640.
Der volle Inhalt der QuellePerrot, Aurore, Valerie Lauwers-Cances, Titouan Cazaubiel, Thierry Facon, Denis Caillot, Lauriane Clement-Filliatre, Margaret Macro et al. „Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial“. Blood 136, Supplement 1 (05.11.2020): 39. http://dx.doi.org/10.1182/blood-2020-134538.
Der volle Inhalt der QuelleBoquoi, Amelie, Soraya Magdalena Banahan, Judith Strapatsas, David Lopez y Niedenhoff, Guido Kobbe, Norbert Gattermann, Ulrich Germing, Rainer Haas, Thomas Schroeder und Roland Fenk. „Therapy-Related Myeloid Neoplasms Following Treatment for Multiple Myeloma : A Single-Center Analysis“. Blood 134, Supplement_1 (13.11.2019): 4261. http://dx.doi.org/10.1182/blood-2019-122598.
Der volle Inhalt der QuelleKreissl, Stefanie, Helen Goergen, Bastian von Tresckow, Karolin Behringer, Jana Markova, Andreas Lohri, Julia Meissner et al. „Primary Progressive Disease in Hodgkin Lymphoma Patients: A Retrospective Analysis from the German Hodgkin Study Group“. Blood 126, Nr. 23 (03.12.2015): 3941. http://dx.doi.org/10.1182/blood.v126.23.3941.3941.
Der volle Inhalt der QuelleBeksac, Meral, Simona Iacobelli, Linda Koster, Didier Blaise, Jan J. Cornelissen, Péter Reményi, Xavier Leleu et al. „A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. a Study of the EBMT Chronic Malignancies Working Party“. Blood 138, Supplement 1 (05.11.2021): 3937. http://dx.doi.org/10.1182/blood-2021-147001.
Der volle Inhalt der QuellePerrot, Aurore, Valérie Lauwers-Cances, Cyrille Touzeau, Olivier Decaux, Cyrille Hulin, Magaret Macro, Anne-Marie Stoppa et al. „Daratumumab Plus Ixazomib, Lenalidomide, and Dexamethasone As Extended Induction and Consolidation Followed By Lenalidomide Maintenance in Standard-Risk Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (IFM 2018-01): A Phase II Study of the Intergroupe Francophone Du Myélome (IFM)“. Blood 138, Supplement 1 (05.11.2021): 464. http://dx.doi.org/10.1182/blood-2021-146040.
Der volle Inhalt der QuelleRücker, Frank G., Mridul Agrawal, Andrea Corbacioglu, Daniela Weber, Silke Kapp-Schwoerer, Verena I. Gaidzik, Nikolaus Jahn et al. „Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1) RUNX1-RUNX1T1 Identifies Patients at High Risk of Relapse: Results of the AML Study Group (AMLSG)“. Blood 134, Supplement_1 (13.11.2019): 2740. http://dx.doi.org/10.1182/blood-2019-125584.
Der volle Inhalt der QuelleNeukirchen, Judith, Pia Arat, Charlotte Teutloff, Celina Gerrlich, David Lopez y Niedenhoff, Amelie Boquoi, Ingrida Savickaite et al. „Favourable Outcome of Elderly Patients with Multiple Myeloma Treated with Tandem Melphalan 100 High-Dose Therapy, Autologous Stem Cell Transplantation and Novel Agents - a Single Center Experience“. Blood 128, Nr. 22 (02.12.2016): 3460. http://dx.doi.org/10.1182/blood.v128.22.3460.3460.
Der volle Inhalt der QuelleKvasnicka, Hans Michael, Juergen Thiele, Carlos E. Bueso-Ramos, William Sun, Ahmad Naim, Smitha Svaraman, Jessy Gao et al. „Effects of Long-Term Ruxolitinib (RUX) on Bone Marrow (BM) Morphology in Patients with Myelofibrosis (MF) Enrolled in the COMFORT-I Study“. Blood 128, Nr. 22 (02.12.2016): 1949. http://dx.doi.org/10.1182/blood.v128.22.1949.1949.
Der volle Inhalt der QuelleThieblemont, Catherine, Loïc Chartier, Ulrich Dührsen, Umberto Vitolo, Sally F. Barrington, Laetitia Vercellino, Jan Zaucha et al. „The Combination of High Total Metabolic Tumor Volume and Poor ECOG Performance Status Defines Ultra-High Risk Diffuse Large B-Cell Lymphoma. Validation across Multiple Cohorts of Large Clinical Trials and in Real World“. Blood 136, Supplement 1 (05.11.2020): 30–31. http://dx.doi.org/10.1182/blood-2020-136544.
Der volle Inhalt der QuelleLandgren, Ola, Melissa Alsina, Noa Biran, David H. Vesole, Paul K. Wallace, Belle Fang, Gregory Arnold, Amy Kimball und David S. Siegel. „Assessment of Minimal Residual Disease in a Phase 1b Study of Once-Weekly Carfilzomib Combined with Lenalidomide and Dexamethasone in Patients with Multiple Myeloma“. Blood 136, Supplement 1 (05.11.2020): 28. http://dx.doi.org/10.1182/blood-2020-133803.
Der volle Inhalt der QuelleHrusak, Ondrej, Valerie De Haas, Ales Luks, Iveta Janotova, Ester Mejstrikova, Kirsten Bleckmann, Anja Moricke et al. „Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies“. Blood 128, Nr. 22 (02.12.2016): 584. http://dx.doi.org/10.1182/blood.v128.22.584.584.
Der volle Inhalt der QuelleMuriawan Putra, Agus, und Ida Bagus Ketut Astina. „The Development of Local Accommodation to Support Subak Jatiluwih Tourism in Tabanan Regency“. Udayana Journal of Social Sciences and Humanities (UJoSSH) 1, Nr. 1 (28.02.2017): 1. http://dx.doi.org/10.24843/ujossh.2017.v01.i01.p01.
Der volle Inhalt der QuelleAvet Loiseau, Herve, Pieter Sonneveld, Philippe Moreau, Fritz Offner, Vincent H. J. van der Velden, Denis Caillot, Cyrille Hulin et al. „Daratumumab (DARA) with Bortezomib, Thalidomide, and Dexamethasone (VTd) in Transplant-Eligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) Negativity in Cassiopeia Part 1 and Part 2“. Blood 138, Supplement 1 (05.11.2021): 82. http://dx.doi.org/10.1182/blood-2021-147897.
Der volle Inhalt der QuelleAvet-Loiseau, Herve, Romain Lannes, Aurore Perrot, Céline Mazzotti, Marion Divoux, Titouan Cazaubiel, Xavier Leleu et al. „In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present from the Diagnosis in Tiny Undetectable Subclones“. Blood 138, Supplement 1 (05.11.2021): 77. http://dx.doi.org/10.1182/blood-2021-146869.
Der volle Inhalt der QuelleThieblemont, Catherine, Maria Gomes da Silva, Olivier Casasnovas, Hervé Ghesquieres, Gandhi Laurent Damaj, Judith Trotman, Pierre Feugier et al. „Final Analysis of the International Double-Blind Randomized Phase III Study of Lenalidomide Maintenance in Elderly Patients with DLBCL in Response after R-CHOP, the Remarc Study from Lysa“. Blood 136, Supplement 1 (05.11.2020): 1–2. http://dx.doi.org/10.1182/blood-2020-136511.
Der volle Inhalt der Quelle